Munich \u2014 Amsilk has closed a Series C finan\u00adcing of EUR 29 million. The finan\u00adcing was led by Novo Growth, the growth equity arm of Novo Holdings, with parti\u00adci\u00adpa\u00adtion from new inves\u00adtors Cargill and E.R. Capi\u00adtal Holdings, as well as exis\u00adting inves\u00adtors MIG and Athos. With the funding, AMSilk aims to scale its global projects as well as inter\u00adna\u00adtio\u00adna\u00adliza\u00adtion. The aim is to reach new indus\u00adtries and customers.<\/p>\n
Envi\u00adron\u00admen\u00adtally friendly and sustainable silk biopolymers Kartik Dhar\u00admad\u00adhi\u00adkari, part\u00adner at Novo Growth, said, \u201cThe tech\u00adno\u00adlogy has the poten\u00adtial to revo\u00adlu\u00adtio\u00adnize a number of indus\u00adtries and be part of the decar\u00adbo\u00adniza\u00adtion push needed to address the biggest envi\u00adron\u00admen\u00adtal chal\u00adlenges of our time.\u201d<\/p>\n Michael Motsch\u00admann, Gene\u00adral Part\u00adner of MIG, added: \u201cAs an Amsilk Seed inves\u00adtor, we are proud of the great progress the company has made since its incep\u00adtion. Our contin\u00adued invest\u00adment in Amsilk reflects our vision to invest in early-stage biotech and deep tech compa\u00adnies and drive inno\u00adva\u00adtion that can advance the world.\u201d<\/p>\n Advi\u00adsor AMSILK: LUTZ | ABEL Rechts\u00adan\u00adwalts PartG mbB<\/strong> About LUTZ | ABEL Munich \u2014 Amsilk has closed a Series C finan\u00adcing of EUR 29 million. The finan\u00adcing was led by Novo Growth, the growth equity arm of Novo Holdings, with parti\u00adci\u00adpa\u00adtion from new inves\u00adtors Cargill and E.R. Capi\u00adtal Holdings, as well as exis\u00adting inves\u00adtors MIG and Athos. With the funding, AMSilk aims to scale its global projects [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":37379,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369],"tags":[],"class_list":["post-43455","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors","news-category-venture-capital-news"],"yoast_head":"\n
\n<\/strong>
\nAMSilk is a leader in the produc\u00adtion of high-perfor\u00admance orga\u00adnic silk mate\u00adri\u00adals with a vision to offer more sustainable products. The silk products are made from vege\u00adta\u00adble raw mate\u00adri\u00adals and are produ\u00adced via bacte\u00adrial fermen\u00adta\u00adtion. Thanks to their versa\u00adtile proper\u00adties, silk products are in demand in many indus\u00adtries, for exam\u00adple in high-perfor\u00admance sports\u00adwear and medi\u00adcal implants. The products are 100 percent recy\u00adclable and biode\u00adgra\u00adda\u00adble. With the funding, AMSilk will acce\u00adle\u00adrate indus\u00adtrial scale-up and reach new markets.<\/p>\n
\nThe consul\u00adting team around Dr. Bern\u00adhard Noreisch, LL.M. (lead) consis\u00adted of Jan-Phil\u00adlip Kunz, LL.M. (both VC\/M&A, Munich) and Dr. Marius Mann (Commer\u00adcial, Stuttgart).<\/p>\n
\nThe commer\u00adcial law firm LUTZ | ABEL advi\u00adses on all aspects of commer\u00adcial law with around 85 lawy\u00aders and offices in Munich, Hamburg, Stutt\u00adgart and Berlin.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"